NCT03221400 2022-02-17
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
Phase 1/2 Unknown
Tarveda Therapeutics
Sun Yat-sen University
Russian Academy of Medical Sciences
HealthCare Global Enterprise Ltd.
Hospital Authority, Hong Kong